Get the Stockscreener App
0.7431
3.68%
-0.0215
Trinity Biotech Plc Adr stock is traded at $0.7431, with a volume of 74,079.
It is down -3.68% in the last 24 hours and down -23.28% over the past month.
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
See More
Previous Close:
$0.7646
Open:
$0.7612
24h Volume:
74,079
Relative Volume:
0.03
Market Cap:
$13.85M
Revenue:
$54.43M
Net Income/Loss:
$-36.70M
P/E Ratio:
-0.2533
EPS:
-2.9334
Net Cash Flow:
$-19.17M
1W Performance:
-6.89%
1M Performance:
-23.28%
6M Performance:
+0.22%
1Y Performance:
-22.06%
1-Day Range:
$0.7301
$0.768
1-Week Range:
$0.72
$0.8002
52-Week Range:
$0.48
$3.44
Trinity Biotech Plc Adr Stock (TRIB) Company Profile
Name
Trinity Biotech Plc Adr
Sector
Industry
Phone
-
Address
-
Compare TRIB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TRIB
Trinity Biotech Plc Adr
|
0.7431 | 14.25M | 54.43M | -36.70M | -19.17M | -2.9334 |
|
ABT
Abbott Laboratories
|
127.00 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.48 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
365.09 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.67 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.86 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Trinity Biotech Plc Adr Stock (TRIB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-23-15 | Downgrade | Craig Hallum | Buy → Hold |
| Sep-03-15 | Initiated | Raymond James | Outperform |
| Jul-29-15 | Reiterated | ROTH Capital | Buy |
| Jul-22-08 | Reiterated | Roth Capital | Buy |
| Mar-17-08 | Reiterated | Roth Capital | Buy |
| Dec-10-07 | Reiterated | Roth Capital | Buy |
| Oct-26-07 | Reiterated | Roth Capital | Buy |
View All
Trinity Biotech Plc Adr Stock (TRIB) Latest News
Trinity Biotech plc (TRIB) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
Trinity Biotech plc's (NASDAQ:TRIB) Share Price Boosted 54% But Its Business Prospects Need A Lift Too - Sahm
Indaptus Therapeutics, Uipath, Trinity Biotech, Sable Offshore And McDonald's: Why These 5 Stocks Are On Investors' Radars Today - Sahm
Dow Gains 100 Points; US Durable Goods Orders Decline In October - Benzinga
TRIB: Revenue declined and losses narrowed in Q2 2025 amid restructuring and funding uncertainty - TradingView — Track All Markets
TRIB: Gross margin rose to 45.2% and Adjusted EBITDA turned positive despite a $5.1m net loss - TradingView — Track All Markets
Trinity Biotech secures $5 million funding, extends credit agreement - Investing.com India
Trinity Biotech stock soars after major HIV test order signals market recovery By Investing.com - Investing.com South Africa
Trinity Biotech stock soars after major HIV test order signals market recovery - Investing.com
Trinity Biotech secures $5 million funding, extends credit agreement By Investing.com - Investing.com South Africa
Trinity Biotech receives 9 million unit order for HIV screening product - Investing.com
Trinity Biotech receives 9 million unit order for HIV screening product By Investing.com - Investing.com South Africa
Trinity Biotech stock rises on expanded rollout of next-gen HbA1c system - Investing.com
Trinity Biotech stock rises on expanded rollout of next-gen HbA1c system By Investing.com - Investing.com South Africa
Trinity Biotech expands rollout of next-gen HbA1c testing system - Investing.com
Trinity Biotech plc (TRIB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Trinity Biotech receives WHO approval for outsourced HIV test manufacturing - Investing.com
Trinity Biotech Announces Collaboration to Advance Epigenetic Analysis for EpiCapture Prostate Cancer Test - GlobeNewswire Inc.
Why You Need Trinity Biotech Plc ADR (TRIB) On Your Watchlist - fostersleader.com
Operating cash flow per share of Trinity Biotech Plc Sponsored ADR Class A – LS:A404JF - TradingView
EBIT per share of Trinity Biotech plc ADR – MUN:TRB0 - TradingView
Top investors say Banco Macro S.A. ADR (BMA) ticks everything they need - Setenews
Trinity Biotech : 2025 AGM Notice Sent to holders of Ordinary Shares - MarketScreener
TRINITY B ADR : Trinity Biotech plc to Present at Sidoti & Company's Micro-Cap Conference on January 10, 2011 - MarketScreener
Upcoming Stock Splits This Week (August 25 to August 29) – Stay Invested - TipRanks
Trinity Biotech plc Appoints Paul Tivnan as Non-Executive Director - MarketScreener
Trinity Biotech appoints Paul Tivnan to board of directors - Investing.com
Trinity Biotech receives approval for offshore manufacturing of HIV test - Investing.com
TRIB’s Market Quandary: Decoding the Ups and Downs of 2025 - investchronicle.com
Trinity Biotech stock soars after NY regulatory approval for preeclampsia test By Investing.com - Investing.com South Africa
Trinity Biotech stock soars after NY regulatory approval for preeclampsia test - Investing.com India
Trinity Biotech receives NY approval for preeclampsia test - Investing.com
Trinity Biotech stock rises on successful CGM calibration-free trial By Investing.com - Investing.com South Africa
Trinity Biotech stock rises on successful CGM calibration-free trial - Investing.com India
Trinity Biotech reports positive results for calibration-free CGM By Investing.com - Investing.com South Africa
Trinity Biotech reports positive results for calibration-free CGM - Investing.com India
Trinity Biotech (TRIB) to Release Earnings on Wednesday - Defense World
Trinity Biotech launches preeclampsia testing service for maternal health By Investing.com - Investing.com South Africa
Trinity Biotech launches preeclampsia testing service for maternal health - Investing.com India
Trinity Biotech Plc Sponsored ADR Class A to Host Earnings Call - ACCESS Newswire
Cadence Bank (CADE) Stock: A Year of Market Fluctuations - investchronicle.com
Trinity Biotech Unveils CGM+: An AI-Native Platform Targeting the $260 Billion AI Wearable Market - Sahm
Trinity Biotech Reaches Profitability Inflection Point, Marking Major Milestone in Strategic Turnaround - MarketScreener
Trinity Biotech Secures Key Regulatory Approval for Offshored and Outsourced Manufacturing of Its Flagship Rapid HIV Test, Accelerating Strategic and Financial Performance Transformation - MarketScreener
Trinity Biotech receives WHO approval for offshore HIV test manufacturing - Investing.com
Trinity Biotech Appoints New Interim CFO - Investing.com
Trinity Biotech Further Strengthens Focus on Continuous Glucose Monitoring – Appoints Barclays to Advise on Ongoing Strategic Realignment Process - MarketScreener
Trinity Biotech stock hits 52-week low at $0.72 amid challenges - Investing.com
Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial - MarketScreener
Trinity Biotech faces US aid policy impact, PPP loan scrutiny - Investing.com
Trinity Biotech announces breakthrough in CGM technology - Investing.com
Trinity Biotech Plc Adr Stock (TRIB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.62%
0.98%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):